EDN1 and chronic thromboembolic pulmonary hypertension: Multiple pathophysiologic processes have been reported to contribute to the progression of CTEPH [17]–[19], including imbalance of endothelin-1 (ET-1), nitric oxide and prostacyclin, dysfunction of pulmonary arterial endothelial cells (PAECs), and malproliferation of PASMCs.